Published in J Am Coll Surg on October 01, 1998
Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg (2005) 1.32
The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium. J Clin Pathol (2001) 1.02
Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J Surg (2001) 0.99
Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep (2013) 0.98
Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World J Hepatol (2010) 0.94
Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma. HPB (Oxford) (2011) 0.88
Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis. Eur J Surg Oncol (2014) 0.87
Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87
Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today (2011) 0.86
Review of endoscopic techniques in the diagnosis and management of cholangiocarcinoma. World J Gastroenterol (2008) 0.86
Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma. World J Gastroenterol (2009) 0.82
The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol (2015) 0.80
Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis. Sci Rep (2016) 0.79
Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) (2008) 0.78
Pancreatic recurrence of intrahepatic cholangiocarcinoma: Case report and review of the literature. World J Gastrointest Surg (2014) 0.75
MRI characteristics for the differential diagnosis of benign and malignant small solitary hypovascular hepatic nodules. Eur J Gastroenterol Hepatol (2016) 0.75
R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis. Dig Dis Sci (2008) 0.75
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study. Br J Cancer (2016) 0.75
Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma. Surg Today (2011) 0.75
Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma. Strahlenther Onkol (2017) 0.75
Overexpression of the X-linked ribosomal protein S4 predicts poor prognosis in patients with intrahepatic cholangiocarcinoma. Oncol Lett (2017) 0.75
Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol (1998) 5.14
Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med (1991) 4.68
Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab (1999) 3.00
The canals of Hering and hepatic stem cells in humans. Hepatology (1999) 2.93
Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J (1998) 2.65
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant (2008) 2.63
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18
Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5. Biochemistry (1993) 2.14
Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med (1989) 2.09
Ivermectin-resistant Ostertagia circumcincta from sheep in the lower North Island and their susceptibility to other macrocyclic lactone anthelmintics. N Z Vet J (2000) 2.07
HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med (1992) 2.03
Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett (1998) 1.96
The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology (1992) 1.85
Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry (2010) 1.83
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
Hepatic 'stem cell' malignancies in adults: four cases. Histopathology (2003) 1.73
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
Expanded indications for laser-assisted balloon angioplasty in peripheral arterial disease. J Vasc Surg (1990) 1.62
Hepatocyte growth factor: a multifunctional cytokine. Lancet (1995) 1.61
One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg (2001) 1.61
Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol (2000) 1.59
Telomerase activity in precancerous hepatic nodules. Cancer (1998) 1.59
Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol (1997) 1.55
N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation (1995) 1.52
Interaction-induced shift of the cyclotron resonance of graphene using infrared spectroscopy. Phys Rev Lett (2010) 1.51
Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet (1990) 1.49
Brucella infection with pancytopenia after pediatric liver transplantation. Transpl Infect Dis (2012) 1.45
Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl (2001) 1.44
The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr (2001) 1.43
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am J Clin Pathol (1995) 1.43
Molecular and cellular pathology of hepatitis B. Lab Invest (1985) 1.43
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis. Arch Pathol Lab Med (1998) 1.42
HLA-DR expression in bile duct damage in hepatitis C. Mod Pathol (1993) 1.42
Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg (1997) 1.41
Use of the superficial femoral vein as a replacement for large veins. J Vasc Surg (1991) 1.40
Distribution of five antigens in hepatocellular carcinoma. Lab Invest (1979) 1.35
Outcome for patients treated with laparoscopic versus open resection of hepatocellular carcinoma: case-matched analysis. Ann Surg Oncol (2009) 1.34
Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant (2000) 1.34
A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg (1995) 1.32
Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32
Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. Am J Surg Pathol (1998) 1.30
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol (2000) 1.30
ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28
Etiology of chronic renal failure in Turkish children. Pediatr Nephrol (1995) 1.27
Identification of bipotential progenitor cells in human liver regeneration. Lab Invest (1996) 1.26
Maternal transmission of immunity to Eimeria maxima: enzyme-linked immunosorbent assay analysis of protective antibodies induced by infection. Infect Immun (1994) 1.25
Preoperative and intraoperative predictors of postoperative morbidity, poor graft function, and early rejection in 190 patients undergoing liver transplantation. Arch Surg (2001) 1.20
Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol (2000) 1.19
In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology (1998) 1.19
Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transpl (2001) 1.17
Liver transplantation for autoimmune hepatitis. Hepatology (2000) 1.16
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology (1995) 1.16
Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis (1996) 1.16
Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro. Lab Invest (1988) 1.15
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. Am J Transplant (2007) 1.13
The molecular genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol (2014) 1.13
Detection of hepatitis C virus RNA using ligation-dependent polymerase chain reaction in formalin-fixed, paraffin-embedded liver tissues. Am J Pathol (1996) 1.12
Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12